Glaukos Corporation revised sales guidance for the year 2022. The company raised 2022 net sales guidance to $275 million to $280 million, compared to $270 million to $275 million previously.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.5 USD | +1.41% | +7.07% | +33.99% |
05-02 | Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating | MT |
05-02 | JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.99% | 5.34B | |
-7.58% | 10.91B | |
+2.17% | 8.93B | |
+22.75% | 7.57B | |
+8.12% | 3.43B | |
-8.48% | 2.81B | |
-5.07% | 2.23B | |
-4.22% | 2.13B | |
-20.87% | 1.84B | |
-4.52% | 1.2B |
- Stock Market
- Equities
- GKOS Stock
- News Glaukos Corporation
- Glaukos Corporation Revises Sales Guidance for the Year 2022